SOLACI-CACI 2021 | EuroPCR Session

✔️ Watch the complete PCR in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI?

  • 04:51 – How does Coronary Artery Disease impact decision-making process of the Heart Team for patients with symptomatic severe AS? – Round Table Discussion
  • 10:59 – ACTIVATION Trial Results – Tiffany Patterson
  • 19:56 – FFR assessment of coronary stenosis found in patients eligible for a TAVI procedure: how does AS influence the measurements? Better to assess FFR before or after TAVI? – Flavio Ribichini
  • 25:40 – How to implement those results in every-day clinical practice? What about ostial RCA, LM or proximal LAD lesions? – Round Table discussion

👉 How to predict, how to avoid peri-procedural coronary obstruction during a TAVI procedure?

  • 33:04 – How to predict peri-procedural coronary obstruction during TAVI – Nicolas Dumonteil
  • 46:42 – BASILICA: technique and outcomes overview – Mohamed Abdel-Wahab
  • 55:20 – Chimney stenting technique: technique overview and results of the International registry – Darren Mylotte

👉 How to solve technical issues during PCI in a patient with a transcatheter heart valve previously implanted

  • 01:09:10 – PCI after TAVI, is it a frequent issue, what are the outcomes? – Marco Barbanti
  • 01:24:10 – My Tips and Tricks for performing a PCI in a patient having been treated by TAVI – Didier Tchétché
  • 01:33:23 – Rationale and simple technique to achieve commissural alignment during your TAVI procedure – Lars Sondergard

✔️ Chairperson: Jean Fajadet, Nicolas Dumonteil & Ernesto Ban Hayashi
✔️ Digital Moderator: Gaspar Caponi
✔️ Panelistas: Abdalla Saad, Jamil – Belardi, Jorge – Berrocal, Daniel – Gutiérrez Jaikel, Luis – Maluenda, Gabriel – Montenegro, Marcio –


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...